|
About ReachBio
We know colony assays!
ReachBio has been performing hematopoietic progenitor/colony-forming cell (CFC) assays and other primary cell-based assays under contract for premier biotechnology and pharmaceutical companies since 2007.
Our scientists have decades of prior experience performing CFC assays in clinical, industrial and academic settings. Our Chief Scientific Officer,
Dr. Emer Clarke, has trained countless individuals around the world on hematopoietic and mesenchymal CFC assays. She also designed and managed the first global proficiency testing program for standardizing hematopoietic CFC assays.
Since our inception, we have used our ColonyGEL™ media for our contract services for such high value industrial applications as drug screening, hemotoxicity testing, cancer stem cell assays, cytokine mimetic identification, evaluation of expanded cell populations, monitoring mobilization kinetics, etc. We are now making our high quality methylcellulose-based ColonyGEL™ media widely available to the broader research community.
We guarantee
that its performance will meet or exceed any media of its kind on the market today!
To learn more about ReachBio, please visit
www.reachbio.com. |
